Abstract

Solitary fibrous tumours can cause non-islet cell tumour-induced hypoglycaemia, a paraneoplastic syndrome resulting from extrapancreatic tumours secreting insulin-like growth factor -II. This is also known as Doege–Potter syndrome. A male patient in his 70s presented to our hospital with loss of consciousness because of a second relapse of the solitary fibrous tumour with Doege–Potter syndrome. A third surgery was performed after transcatheter arterial embolization. After surgery, blood glucose levels stabilized. Repeated relapses can occur in solitary fibrous tumours even after the complete resection. Embolization of the feeding arteries before resection may be effective in avoiding massive haemorrhage and reducing complications.

Introduction

Solitary fibrous tumours (SFT) are rare mesenchymal tumours that primarily develop in the thoracic cavity; however, ~30% of SFTs occur in the abdominopelvic region [1]. Most SFTs appear to be benign; however, up to 20% of these tumours have the potential to recur or metastasize [2, 3]. This tumour rarely develops into Doege–Potter syndrome, a paraneoplastic syndrome caused by extrapancreatic tumours secreting insulin-like growth factor-II (IGF-II) resulting in non-islet cell tumour-induced hypoglycaemia [4]. Herein, we present a case of a second recurrence of abdominopelvic SFT with Doege–Potter syndrome that was successfully treated with transcatheter arterial embolization (TAE) and subsequent surgical resection.

Case presentation

In 2011, a male patient in his 60s presented to the emergency department with loss of consciousness. His blood glucose level was 20 mg/dL. Contrast-enhanced computed tomography (CT) revealed a large tumour measuring 20 cm in diameter (Fig. 1). Primary surgery was performed and the tumour was diagnosed as an SFT histopathologically. Five years later, contrast-enhanced CT revealed a 4-cm tumour in the lower abdomen. His blood glucose levels were normal. A second surgery was performed; the tumour was excised, and several disseminated nodules were cauterized. Histology revealed that the tumour was an SFT. Eight years later, the patient presented with loss of consciousness. Laboratory data revealed a blood glucose level of 28 mg/dL. Contrast-enhanced CT revealed multiple tumours measuring 3–14 cm in diameter, spread within the abdominopelvic regions (Fig. 2). To prevent excessive intraoperative haemorrhage, preoperative TAE was performed on two larger tumours. Angiography revealed that the large tumour in the right lower abdomen was supplied by a branch of the superior mesenteric artery, whereas the pelvic tumour was supplied by branches from the inferior mesenteric and bilateral internal iliac arteries (Fig. 3). Super-selective catheterization and embolization of the vessels were performed. One week after embolization, a third surgery was performed. Nine tumours were resected. The operative time was 177 min, and the estimated blood loss was 620 mL. Histologically, part of the rectal wall showed necrosis. The tumour comprised spindle cells exhibiting a ‘patternless’ arrangement in a collagenous matrix (Fig. 4a). Immunohistochemical staining was positive for CD34, CD99, Bcl-2, and STAT6, which confirmed the diagnosis of recurrent SFT (Fig. 4b and c). The Ki-67 labelling rate was ~10% in the highly labelled regions. The tumour was also positive for insulin-like growth factor-II (Fig. 4d). After surgery, blood glucose levels completely stabilized. The patient developed a paralytic ileus that resolved spontaneously and was discharged 13 days after surgery. The patient was well, with no recurrence noted during the 10-month follow-up period.

Contrast-enhanced CT showing a large tumour measuring 20 cm in diameter occupying both the abdominal and pelvic cavities.
Figure 1

Contrast-enhanced CT showing a large tumour measuring 20 cm in diameter occupying both the abdominal and pelvic cavities.

Contrast-enhanced CT showing a lobulated, ill-defined mass with heterogeneous moderate enhancement in the right lower abdomen (a) and several masses occupying the pelvic cavity (b).
Figure 2

Contrast-enhanced CT showing a lobulated, ill-defined mass with heterogeneous moderate enhancement in the right lower abdomen (a) and several masses occupying the pelvic cavity (b).

Angiographic findings. The large tumour (arrows) located in the right lower abdomen was supplied by a branch arising from the superior mesenteric artery (SMA) (a). The pelvic tumours (arrows) were supplied by branches arising from both the inferior mesenteric artery (IMA) (b) and the bilateral internal iliac arteries (RIIA and LIIA) (c and d).
Figure 3

Angiographic findings. The large tumour (arrows) located in the right lower abdomen was supplied by a branch arising from the superior mesenteric artery (SMA) (a). The pelvic tumours (arrows) were supplied by branches arising from both the inferior mesenteric artery (IMA) (b) and the bilateral internal iliac arteries (RIIA and LIIA) (c and d).

Pathological findings. Haematoxylin and eosin staining of the tumour showing spindle cells exhibiting a ‘patternless’ arrangement in a collagenous matrix (a). Immunohistochemical staining demonstrating that the tumour cells were positive for CD34 (b) and STAT6 (c), consistent with the diagnosis of a solitary fibrous tumour. Immunohistochemical staining showing positivity for insulin-like growth factor -II (IGF-II) in the tumour cells (d).
Figure 4

Pathological findings. Haematoxylin and eosin staining of the tumour showing spindle cells exhibiting a ‘patternless’ arrangement in a collagenous matrix (a). Immunohistochemical staining demonstrating that the tumour cells were positive for CD34 (b) and STAT6 (c), consistent with the diagnosis of a solitary fibrous tumour. Immunohistochemical staining showing positivity for insulin-like growth factor -II (IGF-II) in the tumour cells (d).

Discussion

Approximately 4%–11.5% of patients with SFTs develop Doege-Potter syndrome, and hypoglycaemia occasionally is the initial indicator that leads to the detection of large SFTs [5, 6]. In this case, hypoglycaemia was consistent with the initial presentation and the second recurrence. This could be considered an important diagnostic tool for the clinical diagnosis of SFT, both at initial presentation and at disease recurrence [7]. However, hypoglycaemia was not detected during the second relapse, suggesting that it may only occur in larger tumours. The time between the first and second recurrences was shorter than between the initial diagnosis and first recurrence in frequently-recurring SFTs [8]; however, the time between the first and second recurrences was longer in our patient, possibly because the first recurrence was detected using CT before symptoms appeared. Therefore, follow-up diagnostic imaging is crucial for early detection. Surgical resection of large SFTs can be risky and is associated with massive intraoperative haemorrhage of up to 13 660 mL [9–11]. In large pelvic tumours, preoperative TAE enables safe and complete resection of SFTs [12, 13]. We performed a literature review using PubMed with the key words ‘solitary fibrous tumour/SFT’ and ‘embolisation.’ In addition, we manually searched the reference lists of all identified articles to further select relevant articles, and only extracted cases of SFTs occurring in the pelvis. Preoperative TAE with subsequent resection has been previously reported in seven patients (Table 1). Including the present case, there were four women and four men, with a mean age of 56.8 (34–79) years [12–18]. The tumour sizes were 11–30 cm (mean, 12.3 cm). Only two patients presented with hypoglycaemia that improved after embolization. Embolised arteries, including the obturator, internal pudendal, superior vesical, and medial rectal arteries, are predominantly located in the internal iliac artery system. Rectal ischaemia was observed in two of the three cases following embolization of the superior rectal artery. The estimated blood loss was 200–620 mL (mean, 369 mL), which is relatively small compared with previously reported cases [9–11]. Overall, we consider preoperative embolization to be effective for subsequent elective surgery in patients with severe neoplasm bleeding [19, 20]. However, care should be taken to prevent rectal ischaemia, especially for tumours in which the inferior mesenteric artery is the main feeder, even when performing super-selective TAE of the tumour [12]. Considering the potential for intestinal ischaemia, TAE should be performed only a few days before surgery.

Table 1

Case reports of preoperative TAE followed by subsequent resection of SFTs occurring in the pelvis.

AuthorAge/sexHypoglycaemiaTumour size
(cm)
Site of
TAE
BS level after TAEDuration between TAE & surgery (days)TherapyBlood loss (mL)Complications
related to TAE
Torigoe [14]55/Fno12RIIANA1Tumour excision with HartmannNDnone
Boe [15]52/Mno20NDNANDTumour excisionNDnone
Fard-Aghaie [16]70/Fno19SRA, MRANA14Tumour excision200none
Yokoyama [13]63/Mno30LOA, LIPA, LSVANA30 and 1Tumour excision440none
Yuza [12]46/Fyes17IMA, IIAstable2Tumour excision with LAR335rectal ischemia
Yan [17]55/Mno12IIANANDTumour excisionNDnone
Takahashi [18]34/Fno11ROA, RIPANA1Tumour excision250none
Present case79/Myes14IMA, IIAstable7Tumour excision with LAR620rectal ischemia
AuthorAge/sexHypoglycaemiaTumour size
(cm)
Site of
TAE
BS level after TAEDuration between TAE & surgery (days)TherapyBlood loss (mL)Complications
related to TAE
Torigoe [14]55/Fno12RIIANA1Tumour excision with HartmannNDnone
Boe [15]52/Mno20NDNANDTumour excisionNDnone
Fard-Aghaie [16]70/Fno19SRA, MRANA14Tumour excision200none
Yokoyama [13]63/Mno30LOA, LIPA, LSVANA30 and 1Tumour excision440none
Yuza [12]46/Fyes17IMA, IIAstable2Tumour excision with LAR335rectal ischemia
Yan [17]55/Mno12IIANANDTumour excisionNDnone
Takahashi [18]34/Fno11ROA, RIPANA1Tumour excision250none
Present case79/Myes14IMA, IIAstable7Tumour excision with LAR620rectal ischemia

BS, blood sugar; IIA, internal iliac artery; IMA, inferior mesenteric artery; LAR, low anterior resection; LIPA, left internal pudendal artery; LOA, left obturator artery; LSVA, left superior vesical artery; MRA, medial rectal artery; NA, not applicable; ND, not detailed; RIIA, right internal iliac artery; RIPA, right internal pudendal artery; ROA, right obturator artery; SRA, superior rectal artery.

Table 1

Case reports of preoperative TAE followed by subsequent resection of SFTs occurring in the pelvis.

AuthorAge/sexHypoglycaemiaTumour size
(cm)
Site of
TAE
BS level after TAEDuration between TAE & surgery (days)TherapyBlood loss (mL)Complications
related to TAE
Torigoe [14]55/Fno12RIIANA1Tumour excision with HartmannNDnone
Boe [15]52/Mno20NDNANDTumour excisionNDnone
Fard-Aghaie [16]70/Fno19SRA, MRANA14Tumour excision200none
Yokoyama [13]63/Mno30LOA, LIPA, LSVANA30 and 1Tumour excision440none
Yuza [12]46/Fyes17IMA, IIAstable2Tumour excision with LAR335rectal ischemia
Yan [17]55/Mno12IIANANDTumour excisionNDnone
Takahashi [18]34/Fno11ROA, RIPANA1Tumour excision250none
Present case79/Myes14IMA, IIAstable7Tumour excision with LAR620rectal ischemia
AuthorAge/sexHypoglycaemiaTumour size
(cm)
Site of
TAE
BS level after TAEDuration between TAE & surgery (days)TherapyBlood loss (mL)Complications
related to TAE
Torigoe [14]55/Fno12RIIANA1Tumour excision with HartmannNDnone
Boe [15]52/Mno20NDNANDTumour excisionNDnone
Fard-Aghaie [16]70/Fno19SRA, MRANA14Tumour excision200none
Yokoyama [13]63/Mno30LOA, LIPA, LSVANA30 and 1Tumour excision440none
Yuza [12]46/Fyes17IMA, IIAstable2Tumour excision with LAR335rectal ischemia
Yan [17]55/Mno12IIANANDTumour excisionNDnone
Takahashi [18]34/Fno11ROA, RIPANA1Tumour excision250none
Present case79/Myes14IMA, IIAstable7Tumour excision with LAR620rectal ischemia

BS, blood sugar; IIA, internal iliac artery; IMA, inferior mesenteric artery; LAR, low anterior resection; LIPA, left internal pudendal artery; LOA, left obturator artery; LSVA, left superior vesical artery; MRA, medial rectal artery; NA, not applicable; ND, not detailed; RIIA, right internal iliac artery; RIPA, right internal pudendal artery; ROA, right obturator artery; SRA, superior rectal artery.

Conclusion

Despite our limited experience and the need for future studies to establish the appropriate indications, embolization of the feeding arteries before resection appears to improve surgical outcomes and reduce complications. Given the potential for malignancy, disease recurrence, and metastasis, long-term surveillance using diagnostic imaging is required.

Conflicts of interest

None declared.

Funding

None declared.

References

1.

Wang
 
H
,
Chen
 
P
,
Zhao
 
W
 et al.  
Clinicopathological findings in a case series of abdominopelvic solitary fibrous tumors
.
Oncol Lett
 
2014
;
7
:
1067
72
.

2.

Gold
 
JS
,
Antonescu
 
CR
,
Hajdu
 
C
 et al.  
Clinicopathologic correlates of solitary fibrous tumors
.
Cancer
 
2002
;
94
:
1057
68
.

3.

Hasegawa
 
T
,
Matsuno
 
Y
,
Shimoda
 
T
 et al.  
Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior
.
Hum Pathol
 
1999
;
30
:
1464
73
.

4.

Fukuda
 
I
,
Asai
 
A
,
Nagamine
 
T
 et al.  
Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature
.
Endocr J
 
2017
;
64
:
719
26
.

5.

Han
 
G
,
Zhang
 
Z
,
Shen
 
X
 et al.  
Doege-potter syndrome: a review of the literature including a new case report
.
Medicine (Baltimore)
 
2017
;
96
:
e7417
.

6.

Ishihara
 
H
,
Omae
 
K
,
Iizuka
 
J
 et al.  
Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: a case report with protein analysis
.
Oncol Lett
 
2016
;
12
:
479
84
.

7.

Rose
 
MG
,
Tallini
 
G
,
Pollak
 
J
 et al.  
Malignant hypoglycemia associated with a large mesenchymal tumor: case report and review of literature
.
Cancer J Sci Am
 
1999
;
5
:
48
51
.

8.

Baldi
 
GG
,
Stacchiotti
 
S
,
Mauro
 
V
 et al.  
Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients
.
Clin Sarcoma Res
 
2013
;
3
:
4
.

9.

Kim
 
MY
,
Jeon
 
S
,
Choi
 
SD
 et al.  
A case of solitary fibrous tumor in the pelvis presenting massive hemorrhage during surgery
.
Obstet Gynecol Sci
 
2015
;
58
:
73
6
.

10.

Wada
 
Y
,
Okano
 
K
,
Ando
 
Y
 et al.  
A solitary fibrous tumor in the pelvic cavity of a patient with Doege–potter syndrome: a case report
.
Surg Case Rep
 
2019
;
5
:
60
.

11.

Soda
 
H
,
Kainuma
 
O
,
Yamamoto
 
H
 et al.  
Giant intrapelvic solitary fibrous tumor arising from mesorectum
.
Clin J Gastroenterol
 
2010
;
3
:
136
9
.

12.

Yuza
 
K
,
Sakata
 
J
,
Nagaro
 
H
 et al.  
A giant pelvic solitary fibrous tumor with Doege–potter syndrome successfully treated with transcatheter arterial embolization followed by surgical resection: a case report
.
Surg Case Rep
 
2020
;
6
:
299
305
.

13.

Yokoyama
 
Y
,
Hata
 
K
,
Kanazawa
 
T
 et al.  
Giant solitary fibrous tumor of the pelvis successfully treated with preoperative embolization and surgical resection: a case report
.
World J Surg Oncol
 
2015
;
13
:
164
7
.

14.

Torigoe
 
T
,
Higure
 
A
,
Hirata
 
K
 et al.  
Malignant hemangiopericytoma in the pelvic cavity successfully treated by combined-modality therapy: report of a case
.
Surg Today
 
2003
;
33
:
478
82
.

15.

Boe
 
J
,
Chimpiri
 
AR
,
Liu
 
CZ
.
Solitary fibrous tumor originating in the pelvis: a case report
.
J Radiol Case Rep
 
2010
;
4
:
21
8
.

16.

Fard-Aghaie
 
M
,
Stavrou
 
GA
,
Honarpisheh
 
H
 et al.  
Large hemangiopericytoma of the pelvis--towards a multidisciplinary approach
.
World J Surg Oncol
 
2015
;
13
:
261
6
.

17.

Yan
 
X
,
Zheng
 
C
,
Wang
 
J
 et al.  
Transcatheter arterial embolization of malignant pelvic solitary fibrous tumor: case report and literature review
.
Transl Cancer Res
 
2021
;
10
:
4979
87
.

18.

Takahashi
 
A
,
Nishimura
 
H
,
Amano
 
T
 et al.  
An abdominal-sacral approach with preoperative embolisation for vulvar solitary fibrous tumour: a case report
.
World J Surg Oncl
 
2021
;
19
:
92
8
.

19.

Tanemura
 
M
,
Cho
 
A
,
Niwa
 
Y
 et al.  
Successful embolization with subsequent pancreaticoduodenectomy for intraductal papillary mucinous neoplasm hemorrhage: a case report and review of literature
.
Clin J Gastroenterol
 
2024
;
17
:
1118
24
.

20.

Shibano
 
A
,
Cho
 
A
,
Mouri
 
T
 et al.  
Successful management by laparoscopic total gastrectomy following embolization for gastric cancer with overt bleeding: two case reports
.
J Surg Case Rep
 
2025
;
2025
:
rjaf211
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.